Charanjit Dhillon
Director/Board Member at OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC
Profile
Charanjit Cheryl Dhillon is currently serving as a Non-Executive Director at Oxford Cannabinoid Technologies Ltd.
and as a Senior Independent Non-Executive Director at Oxford Cannabinoid Technologies Holdings Plc.
Previously, Dhillon worked as the Director-Finance at Lorantis Ltd.
Dhillon holds an MBA from the University of Hertfordshire.
Charanjit Dhillon active positions
| Companies | Position | Start |
|---|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Director/Board Member | 2021-04-22 |
Oxford Cannabinoid Technologies Ltd.
 Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - |
Former positions of Charanjit Dhillon
| Companies | Position | End |
|---|---|---|
Lorantis Ltd.
 Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Lorantis Ltd. used to discover and develop drugs. The company had discovered a fundamental immune mechanism, by which the immune response to any disease-causing antigen may be suppressed. It used pursue immunology drug discovery and development programmes to address unmet medical needs. Lorantis was founded in 1998 and was headquartered in Cambridge, UK | Director of Finance/CFO | 2005-09-30 |
Training of Charanjit Dhillon
| University of Hertfordshire | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Health Technology |
| Private companies | 2 |
|---|---|
Lorantis Ltd.
Lorantis Ltd. Pharmaceuticals: MajorHealth Technology Lorantis Ltd. used to discover and develop drugs. The company had discovered a fundamental immune mechanism, by which the immune response to any disease-causing antigen may be suppressed. It used pursue immunology drug discovery and development programmes to address unmet medical needs. Lorantis was founded in 1998 and was headquartered in Cambridge, UK | Health Technology |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Oxford Cannabinoid Technologies Ltd. engages in researching, developing and licensing cannabinoid-based compounds and therapies. Its therapies are used in medical applications, such as inflammatory diseases (arthritis, and auto-immune inflammatory and inflammatory eye diseases), oncology, neurological disorders (addiction, Alzheimer’s, depression, epilepsy, and Parkinson’s disease) and pain management. The company was founded in 2017 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Charanjit Dhillon
